E. Ohman J:or Asset Management’s Rhythm Pharmaceuticals RYTM Stock Holding History

E. Ohman J:or Asset Management’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$613K	Buy	5,523 +1,114	+25%	+$101K	0.01%	383
2026 Q1	$383K	Sell	4,409 -2,180	-33%	-$212K	0.01%	438
2025 Q4	$705K	Sell	6,589 -1,624	-20%	-$172K	0.02%	362
2025 Q3	$829K	Hold	8,213	–	–	0.02%	304
2025 Q2	$519K	Buy	+8,213	New	+$503K	0.01%	364

Other funds holding RYTM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

EWP

Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

E. Ohman J:or Asset Management's RYTM Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its Rhythm Pharmaceuticals (RYTM) stake by 25% in Q2 2026, buying an estimated $101K and bringing the position to 5,523 shares worth $613K. The position accounts for 0.01% of the portfolio, ranked #383.

E. Ohman J:or Asset Management first reported a position in RYTM in Q2 2025 and has held it in 5 quarters since. The position peaked at $829K in Q3 2025. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

E. Ohman J:or Asset Management held 5,523 shares of Rhythm Pharmaceuticals worth $613K as of Q2 2026.
E. Ohman J:or Asset Management bought 1,114 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $101K.
Rhythm Pharmaceuticals made up 0.01% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #383 holding.
E. Ohman J:or Asset Management first reported a position in Rhythm Pharmaceuticals in Q2 2025 and has held it in 5 quarters since.
E. Ohman J:or Asset Management's Rhythm Pharmaceuticals position peaked at $829K in Q3 2025.
20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.